{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:31:42Z","timestamp":1781652702801,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T00:00:00Z","timestamp":1533686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Deanship of Academic Research and Quality Assurance\u2014The University of Jordan"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jiph.2018.07.011","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T02:06:20Z","timestamp":1534989980000},"page":"21-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Extended-spectrum \u03b2-lactamase producing E. coli in urinary tract infections: A two-center, cross-sectional study of prevalence, genotypes and risk factors in Amman, Jordan"],"prefix":"10.1016","volume":"12","author":[{"given":"Sayida A.","family":"Al-Jamei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abla Y.","family":"Albsoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faris G.","family":"Bakri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-5301","authenticated-orcid":false,"given":"Amal G.","family":"Al-Bakri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiph.2018.07.011_bib0005","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1128\/AAC.00066-11","article-title":"Antimicrobial resistance in urinary tract pathogens in Canada from 2007 to 2009: CANWARD surveillance study","volume":"55","author":"Karlowsky","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2018.07.011_bib0010","article-title":"ESBLs: a clear and present danger?","volume":"2012","author":"Dhillon","year":"2012","journal-title":"Crit Care Res Pract"},{"key":"10.1016\/j.jiph.2018.07.011_bib0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1469-0691.2007.01849.x","article-title":"IRT and CMT beta-lactamases and inhibitor resistance","volume":"14","author":"Canton","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiph.2018.07.011_bib0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum beta-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiph.2018.07.011_bib0025","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1086\/502575","article-title":"Colonization status and appropriate antibiotic therapy for nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in an intensive care unit","volume":"26","author":"Blot","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiph.2018.07.011_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0732-8893(99)00108-X","article-title":"High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care units","volume":"36","author":"Shehabia","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2018.07.011_bib0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.9734\/BMRJ\/2012\/1360","article-title":"First report of multidrug-resistant ESBL-producing urinary Escherichia coli in Jordan","volume":"2","author":"Nimri","year":"2012","journal-title":"Br Microbiol Res J"},{"key":"10.1016\/j.jiph.2018.07.011_bib0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijid.2015.04.011","article-title":"Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011\u20132013","volume":"35","author":"Hayajneh","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiph.2018.07.011_bib0045","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-sixth informational supplement update M100-S26","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"10.1016\/j.jiph.2018.07.011_bib0050","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1365-2672.1998.00385.x","article-title":"Development and use of a multiplex PCR system for the rapid screening of heat labile toxin I, heat stable toxin II and shiga-like toxin I and II genes of Escherichia coli in water","volume":"84","author":"Tsen","year":"1998","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.jiph.2018.07.011_bib0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jac\/dkp498","article-title":"Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae","volume":"65","author":"Dallenne","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2018.07.011_bib0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmicb.2012.00110","article-title":"CTX-M enzymes: origin and diffusion","volume":"3","author":"Canton","year":"2012","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.jiph.2018.07.011_bib0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0256-4947.55306","article-title":"Prevalence and molecular characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia","volume":"29","author":"Al-Agamy","year":"2009","journal-title":"Ann Saudi Med"},{"issue":"4","key":"10.1016\/j.jiph.2018.07.011_bib0070","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2016.04.022","article-title":"Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010\u20132014","volume":"85","author":"Lob","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiph.2018.07.011_bib0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2807\/ese.13.47.19044-en","article-title":"Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe","volume":"13","author":"Coque","year":"2008","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.jiph.2018.07.011_bib0080","first-page":"93","article-title":"Detection of extendedspectrum beta-lactamase enzymes (ESBLS) produced by Escherichia coli urinary pathogens at assiut university hospital","volume":"34","author":"Thabit","year":"2011","journal-title":"Bull Pharm Sci"},{"issue":"7","key":"10.1016\/j.jiph.2018.07.011_bib0085","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajic.2012.09.016","article-title":"Resistance trends and risk factors of extended spectrum beta-lactamases in Escherichia coli infections in Aleppo, Syria","volume":"41","author":"Al-Assil","year":"2013","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jiph.2018.07.011_bib0090","first-page":"1364","article-title":"Epidemiology and susceptibility of pathogens from SMART 2011\u201312 Turkey: evaluation of hospital-acquired versus community-acquired urinary tract infections and ICU- versus non-ICU-associated intra-abdominal infections","volume":"72","author":"Koksal","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2018.07.011_bib0095","first-page":"9","article-title":"Molecular and phenotypic characterization of carbapenem resistance and extended spectrum beta lactamese among urinary Escherichia coli isolates","volume":"5","author":"Muhammad","year":"2015","journal-title":"Int J Sci Technol"},{"key":"10.1016\/j.jiph.2018.07.011_bib0100","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/513874","article-title":"Extended spectrum beta-lactamases among gram-negative bacterial isolates from clinical specimens in three major hospitals in northern Jordan","volume":"2009","author":"Batchoun","year":"2009","journal-title":"Int J Microbiol"},{"issue":"10","key":"10.1016\/j.jiph.2018.07.011_bib0105","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s10096-015-2437-3","article-title":"Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis","volume":"34","author":"Vibet","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jiph.2018.07.011_bib0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1469-0691.2007.01869.x","article-title":"Prevalence of extended-spectrum beta-lactamases in South America","volume":"14","author":"Villegas","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.jiph.2018.07.011_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(16)30386-3","article-title":"A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail","volume":"17","author":"Goff","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jiph.2018.07.011_bib0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2005.07.014","article-title":"Community consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriateness","volume":"26","author":"Al-Bakri","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jiph.2018.07.011_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jsps.2011.11.005","article-title":"Knowledge, attitudes and behavior regarding antibiotics use and misuse among adults in the community of Jordan. A pilot study","volume":"20","author":"Shehadeh","year":"2012","journal-title":"Saudi Pharm J"},{"issue":"2","key":"10.1016\/j.jiph.2018.07.011_bib0130","first-page":"138","article-title":"Nosocomial and community infections due to class A extended-spectrum \u03b2-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil","volume":"15","author":"Wollheim","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jiph.2018.07.011_bib0135","first-page":"650","article-title":"Phenotypic and molecular characterization of SHV, TEM, CTX-M and extended-spectrum-lactamase produced by Escherichia coli, Acinobacter baumannii and Klebsiella isolates in a Turkish hospital","volume":"4","author":"Bali","year":"2010","journal-title":"Afr J Microbiol Res"},{"issue":"3","key":"10.1016\/j.jiph.2018.07.011_bib0140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3855\/jidc.3809","article-title":"Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital","volume":"8","author":"Hassan","year":"2014","journal-title":"J Infect Dev Ctries"},{"issue":"10","key":"10.1016\/j.jiph.2018.07.011_bib0145","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/JCM.01555-13","article-title":"Four main virotypes among extended-spectrum-beta-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics","volume":"51","author":"Blanco","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.jiph.2018.07.011_bib0150","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1586\/eri.12.110","article-title":"Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment","volume":"10","author":"Pitout","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.jiph.2018.07.011_bib0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/mdr.2010.0132","article-title":"The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones","volume":"17","author":"Naseer","year":"2011","journal-title":"Microb Drug Resist"},{"issue":"11","key":"10.1016\/j.jiph.2018.07.011_bib0160","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1128\/AAC.49.11.4667-4670.2005","article-title":"Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases","volume":"49","author":"Pitout","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiph.2018.07.011_bib0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00134-008-1237-y","article-title":"Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control","volume":"35","author":"Hanberger","year":"2009","journal-title":"Intens Care Med"},{"issue":"5","key":"10.1016\/j.jiph.2018.07.011_bib0170","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jiph.2018.07.011_bib0175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1469-0691.2009.02941.x","article-title":"Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections","volume":"16","author":"Azap","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.jiph.2018.07.011_bib0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4111\/kju.2010.51.7.492","article-title":"Prevalence and risk factors for extended spectrum beta-lactamase-producing uropathogens in patients with urinary tract infection","volume":"51","author":"Lee","year":"2010","journal-title":"Korean J Urol"},{"issue":"2","key":"10.1016\/j.jiph.2018.07.011_bib0185","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/ped.13112","article-title":"Childhood urinary tract infection caused by extended-spectrum \u03b2-lactamase-producing bacteria: risk factors and empiric therapy","volume":"59","author":"Uyar Aksu","year":"2016","journal-title":"Pediatr Int"},{"issue":"4","key":"10.1016\/j.jiph.2018.07.011_bib0190","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/jac\/dkl035","article-title":"Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases","volume":"57","author":"Calbo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiph.2018.07.011_bib0195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijid.2015.03.006","article-title":"Urinary tract infections due to extended-spectrum beta-lactamase-producing Gram-negative bacteria: identification of risk factors and outcome predictors in an Australian tertiary referral hospital","volume":"34","author":"Osthoff","year":"2015","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034118301163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034118301163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:04:04Z","timestamp":1761750244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034118301163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1876034118301163"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2018.07.011","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extended-spectrum \u03b2-lactamase producing E. coli in urinary tract infections: A two-center, cross-sectional study of prevalence, genotypes and risk factors in Amman, Jordan","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2018.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Production and hosting by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}